Literature DB >> 12149286

Intravesical therapy for superficial cancer: need for more options.

E David Crawford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149286     DOI: 10.1200/JCO.2002.20.15.3185

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience.

Authors:  Lamont J Barlow; James M McKiernan; Mitchell C Benson
Journal:  World J Urol       Date:  2009-02-13       Impact factor: 4.226

2.  In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.

Authors:  V Mey; E Giovannetti; F De Braud; S Nannizzi; G Curigliano; F Verweij; O De Cobelli; S Pece; M Del Tacca; R Danesi
Journal:  Br J Cancer       Date:  2006-07-25       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.